Cerity Partners LLC increased its position in HCA Healthcare, Inc. (NYSE:HCA – Get Rating) by 41.2% in the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 2,571 shares of the company’s stock after purchasing an additional 750 shares during the quarter. Cerity Partners LLC’s holdings in HCA Healthcare were worth $432,000 as of its most recent SEC filing.
A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in HCA. GoalVest Advisory LLC acquired a new position in shares of HCA Healthcare during the 1st quarter worth about $26,000. Wolff Wiese Magana LLC grew its position in shares of HCA Healthcare by 1,833.3% during the 1st quarter. Wolff Wiese Magana LLC now owns 116 shares of the company’s stock worth $29,000 after buying an additional 110 shares during the period. San Luis Wealth Advisors LLC acquired a new position in shares of HCA Healthcare during the 1st quarter worth about $35,000. Covestor Ltd grew its position in shares of HCA Healthcare by 122.7% during the 1st quarter. Covestor Ltd now owns 167 shares of the company’s stock worth $42,000 after buying an additional 92 shares during the period. Finally, SeaCrest Wealth Management LLC acquired a new position in shares of HCA Healthcare during the 2nd quarter worth about $33,000. 65.75% of the stock is currently owned by institutional investors and hedge funds.
HCA Healthcare Stock Up 1.2 %
HCA stock opened at $230.08 on Friday. The company has a current ratio of 1.38, a quick ratio of 1.17 and a debt-to-equity ratio of 87.46. The firm has a market capitalization of $65.05 billion, a PE ratio of 13.00, a PEG ratio of 1.85 and a beta of 1.70. HCA Healthcare, Inc. has a 1-year low of $164.47 and a 1-year high of $279.02. The business’s 50 day simple moving average is $208.28 and its 200 day simple moving average is $202.38.
HCA Healthcare Announces Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, December 28th. Shareholders of record on Wednesday, December 14th will be issued a $0.56 dividend. This represents a $2.24 dividend on an annualized basis and a yield of 0.97%. The ex-dividend date of this dividend is Tuesday, December 13th. HCA Healthcare’s dividend payout ratio is 12.66%.
Insider Buying and Selling at HCA Healthcare
In other HCA Healthcare news, insider Charles J. Hall sold 9,838 shares of the company’s stock in a transaction on Friday, October 28th. The stock was sold at an average price of $223.50, for a total value of $2,198,793.00. Following the transaction, the insider now directly owns 199,883 shares of the company’s stock, valued at approximately $44,673,850.50. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. In other news, insider Charles J. Hall sold 9,838 shares of the company’s stock in a transaction on Friday, October 28th. The stock was sold at an average price of $223.50, for a total transaction of $2,198,793.00. Following the completion of the sale, the insider now directly owns 199,883 shares in the company, valued at approximately $44,673,850.50. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, insider A Bruce Moore, Jr. sold 10,000 shares of the company’s stock in a transaction on Friday, November 11th. The shares were sold at an average price of $224.07, for a total value of $2,240,700.00. Following the sale, the insider now owns 30,807 shares of the company’s stock, valued at $6,902,924.49. The disclosure for this sale can be found here. Insiders have sold a total of 30,170 shares of company stock valued at $6,700,630 in the last ninety days. 1.50% of the stock is currently owned by corporate insiders.
Analyst Upgrades and Downgrades
HCA has been the topic of several recent analyst reports. SVB Leerink cut their price objective on HCA Healthcare from $252.00 to $238.00 and set an “outperform” rating on the stock in a report on Monday, October 24th. StockNews.com upgraded HCA Healthcare from a “buy” rating to a “strong-buy” rating in a report on Friday, November 11th. Stephens cut their price objective on HCA Healthcare from $230.00 to $220.00 and set an “overweight” rating on the stock in a report on Monday, October 24th. Cowen cut their target price on HCA Healthcare to $238.00 in a research note on Monday, July 25th. Finally, Royal Bank of Canada cut their target price on HCA Healthcare from $249.00 to $239.00 and set an “outperform” rating on the stock in a research note on Monday, October 24th. One equities research analyst has rated the stock with a sell rating, two have given a hold rating, fifteen have issued a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat, HCA Healthcare presently has an average rating of “Moderate Buy” and an average price target of $235.10.
HCA Healthcare Company Profile
HCA Healthcare, Inc, through its subsidiaries, provides health care services company in the United States. The company operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.
- Get a free copy of the StockNews.com research report on HCA Healthcare (HCA)
- MarketBeat: Week in Review 11/14 – 11/18
- Target’s Double Bottom Might Have Just Been Confirmed
- How High Can the Fed Go? How to Trade it
- Does ASML’s November Rally Have Staying Power?
- Verra Mobility Stock Has Returned Back to the Station
Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.